 | • レポートコード：MRC2012A2613 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、凝固阻止剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。凝固阻止剤の種類別市場規模（抗血小板凝集阻害剤（PAI）、低分子量ヘパリン（LMWH）、直接トロンビン阻害剤（DTI）、直接因子Xa阻害剤（DFXa）、ビタミンK拮抗薬（VKA）、その他）、用途別市場規模（VTE、ACS/MI、AF、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sanofi、Aspen、Johnson & Johnson、Bayer、Bristol-Myers Squibb、Boehringer Ingelheim、Otsuka、AstraZeneca、Genentech (Roche)、Lilly、Pfizer、Daiichi Sankyo、The Medicines Company、 ・地域別グローバル市場分析 2015年-2020年 ・凝固阻止剤の北米市場（アメリカ、カナダ、メキシコ） ・凝固阻止剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・凝固阻止剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・凝固阻止剤の南米市場（ブラジル、アルゼンチン） ・凝固阻止剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：抗血小板凝集阻害剤（PAI）、低分子量ヘパリン（LMWH）、直接トロンビン阻害剤（DTI）、直接因子Xa阻害剤（DFXa）、ビタミンK拮抗薬（VKA）、その他 ・用途別分析：VTE、ACS/MI、AF、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Decoagulant market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Decoagulant market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Decoagulant market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Decoagulant market has been segmented into
Platelet aggregation inhibitors (PAI)
Low-molecular-weight Heparin (LMWH)
Direct thrombin inhibitor (DTI)
Direct factor Xa inhibitors (DFXa)
Vitamin K antagonists (VKA)
Others
By Application, Decoagulant has been segmented into:
VTE
ACS/MI
AF
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Decoagulant market presented in the report. This section sheds light on the sales growth of different regional and country-level Decoagulant markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Decoagulant market.
The report offers in-depth assessment of the growth and other aspects of the Decoagulant market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Decoagulant Market Share Analysis
Decoagulant competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Decoagulant sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Decoagulant sales, revenue and market share for each player covered in this report.
The major players covered in Decoagulant are:
Sanofi
Aspen
Johnson & Johnson
Bayer
Bristol-Myers Squibb
Boehringer Ingelheim
Otsuka
AstraZeneca
Genentech (Roche)
Lilly
Pfizer
Daiichi Sankyo
The Medicines Company
Among other players domestic and global, Decoagulant market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Decoagulant product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Decoagulant, with price, sales, revenue and global market share of Decoagulant in 2018 and 2019.
Chapter 3, the Decoagulant competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Decoagulant breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Decoagulant market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Decoagulant sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Decoagulant Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Decoagulant Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Platelet aggregation inhibitors (PAI)
1.2.3 Low-molecular-weight Heparin (LMWH)
1.2.4 Direct thrombin inhibitor (DTI)
1.2.5 Direct factor Xa inhibitors (DFXa)
1.2.6 Vitamin K antagonists (VKA)
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Decoagulant Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Others
1.4 Overview of Global Decoagulant Market
1.4.1 Global Decoagulant Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Aspen
2.2.1 Aspen Details
2.2.2 Aspen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Aspen SWOT Analysis
2.2.4 Aspen Product and Services
2.2.5 Aspen Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer SWOT Analysis
2.4.4 Bayer Product and Services
2.4.5 Bayer Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bristol-Myers Squibb SWOT Analysis
2.5.4 Bristol-Myers Squibb Product and Services
2.5.5 Bristol-Myers Squibb Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boehringer Ingelheim SWOT Analysis
2.6.4 Boehringer Ingelheim Product and Services
2.6.5 Boehringer Ingelheim Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Otsuka
2.7.1 Otsuka Details
2.7.2 Otsuka Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Otsuka SWOT Analysis
2.7.4 Otsuka Product and Services
2.7.5 Otsuka Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AstraZeneca SWOT Analysis
2.8.4 AstraZeneca Product and Services
2.8.5 AstraZeneca Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Genentech (Roche)
2.9.1 Genentech (Roche) Details
2.9.2 Genentech (Roche) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Genentech (Roche) SWOT Analysis
2.9.4 Genentech (Roche) Product and Services
2.9.5 Genentech (Roche) Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Lilly
2.10.1 Lilly Details
2.10.2 Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Lilly SWOT Analysis
2.10.4 Lilly Product and Services
2.10.5 Lilly Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Pfizer SWOT Analysis
2.11.4 Pfizer Product and Services
2.11.5 Pfizer Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Daiichi Sankyo
2.12.1 Daiichi Sankyo Details
2.12.2 Daiichi Sankyo Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Daiichi Sankyo SWOT Analysis
2.12.4 Daiichi Sankyo Product and Services
2.12.5 Daiichi Sankyo Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 The Medicines Company
2.13.1 The Medicines Company Details
2.13.2 The Medicines Company Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 The Medicines Company SWOT Analysis
2.13.4 The Medicines Company Product and Services
2.13.5 The Medicines Company Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Decoagulant Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Decoagulant Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Decoagulant Manufacturer Market Share in 2019
3.3.2 Top 6 Decoagulant Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Decoagulant Sales, Revenue and Market Share by Regions
4.1.1 Global Decoagulant Sales and Market Share by Regions (2015-2020)
4.1.2 Global Decoagulant Revenue and Market Share by Regions (2015-2020)
4.2 North America Decoagulant Sales and Growth Rate (2015-2020)
4.3 Europe Decoagulant Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Decoagulant Sales and Growth Rate (2015-2020)
4.5 South America Decoagulant Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Decoagulant Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Decoagulant Sales, Revenue and Market Share by Country
5.1.1 North America Decoagulant Sales and Market Share by Country (2015-2020)
5.1.2 North America Decoagulant Revenue and Market Share by Country (2015-2020)
5.2 United States Decoagulant Sales and Growth Rate (2015-2020)
5.3 Canada Decoagulant Sales and Growth Rate (2015-2020)
5.4 Mexico Decoagulant Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Decoagulant Sales, Revenue and Market Share by Country
6.1.1 Europe Decoagulant Sales and Market Share by Country (2015-2020)
6.1.2 Europe Decoagulant Revenue and Market Share by Country (2015-2020)
6.2 Germany Decoagulant Sales and Growth Rate (2015-2020)
6.3 UK Decoagulant Sales and Growth Rate (2015-2020)
6.4 France Decoagulant Sales and Growth Rate (2015-2020)
6.5 Russia Decoagulant Sales and Growth Rate (2015-2020)
6.6 Italy Decoagulant Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Decoagulant Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Decoagulant Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Decoagulant Revenue and Market Share by Regions (2015-2020)
7.2 China Decoagulant Sales and Growth Rate (2015-2020)
7.3 Japan Decoagulant Sales and Growth Rate (2015-2020)
7.4 Korea Decoagulant Sales and Growth Rate (2015-2020)
7.5 India Decoagulant Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Decoagulant Sales and Growth Rate (2015-2020)
7.7 Australia Decoagulant Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Decoagulant Sales, Revenue and Market Share by Country
8.1.1 South America Decoagulant Sales and Market Share by Country (2015-2020)
8.1.2 South America Decoagulant Revenue and Market Share by Country (2015-2020)
8.2 Brazil Decoagulant Sales and Growth Rate (2015-2020)
8.3 Argentina Decoagulant Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Decoagulant Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Decoagulant Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Decoagulant Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Decoagulant Sales and Growth Rate (2015-2020)
9.3 Turkey Decoagulant Sales and Growth Rate (2015-2020)
9.4 Egypt Decoagulant Sales and Growth Rate (2015-2020)
9.5 South Africa Decoagulant Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Decoagulant Sales and Market Share by Type (2015-2020)
10.2 Global Decoagulant Revenue and Market Share by Type (2015-2020)
10.3 Global Decoagulant Price by Type (2015-2020)
11 Global Decoagulant Market Segment by Application
11.1 Global Decoagulant Sales Market Share by Application (2015-2020)
11.2 Global Decoagulant Revenue Market Share by Application (2015-2020)
11.3 Global Decoagulant Price by Application (2015-2020)
12 Market Forecast
12.1 Global Decoagulant Sales, Revenue and Growth Rate (2021-2025)
12.2 Decoagulant Market Forecast by Regions (2021-2025)
12.2.1 North America Decoagulant Market Forecast (2021-2025)
12.2.2 Europe Decoagulant Market Forecast (2021-2025)
12.2.3 Asia-Pacific Decoagulant Market Forecast (2021-2025)
12.2.4 South America Decoagulant Market Forecast (2021-2025)
12.2.5 Middle East & Africa Decoagulant Market Forecast (2021-2025)
12.3 Decoagulant Market Forecast by Type (2021-2025)
12.3.1 Global Decoagulant Sales Forecast by Type (2021-2025)
12.3.2 Global Decoagulant Market Share Forecast by Type (2021-2025)
12.4 Decoagulant Market Forecast by Application (2021-2025)
12.4.1 Global Decoagulant Sales Forecast by Application (2021-2025)
12.4.2 Global Decoagulant Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Decoagulant Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Decoagulant by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Decoagulant Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Decoagulant Major Business
Table 9. Sanofi Decoagulant Total Revenue (USD Million) (2017-2018)
Table 10. Sanofi SWOT Analysis
Table 11. Sanofi Decoagulant Product and Services
Table 12. Sanofi Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Aspen Basic Information, Manufacturing Base and Competitors
Table 14. Aspen Decoagulant Major Business
Table 15. Aspen Decoagulant Total Revenue (USD Million) (2017-2018)
Table 16. Aspen SWOT Analysis
Table 17. Aspen Decoagulant Product and Services
Table 18. Aspen Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 20. Johnson & Johnson Decoagulant Major Business
Table 21. Johnson & Johnson Decoagulant Total Revenue (USD Million) (2017-2018)
Table 22. Johnson & Johnson SWOT Analysis
Table 23. Johnson & Johnson Decoagulant Product and Services
Table 24. Johnson & Johnson Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Bayer Basic Information, Manufacturing Base and Competitors
Table 26. Bayer Decoagulant Major Business
Table 27. Bayer Decoagulant Total Revenue (USD Million) (2017-2018)
Table 28. Bayer SWOT Analysis
Table 29. Bayer Decoagulant Product and Services
Table 30. Bayer Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 32. Bristol-Myers Squibb Decoagulant Major Business
Table 33. Bristol-Myers Squibb Decoagulant Total Revenue (USD Million) (2017-2018)
Table 34. Bristol-Myers Squibb SWOT Analysis
Table 35. Bristol-Myers Squibb Decoagulant Product and Services
Table 36. Bristol-Myers Squibb Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 38. Boehringer Ingelheim Decoagulant Major Business
Table 39. Boehringer Ingelheim Decoagulant Total Revenue (USD Million) (2017-2018)
Table 40. Boehringer Ingelheim SWOT Analysis
Table 41. Boehringer Ingelheim Decoagulant Product and Services
Table 42. Boehringer Ingelheim Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Otsuka Basic Information, Manufacturing Base and Competitors
Table 44. Otsuka Decoagulant Major Business
Table 45. Otsuka Decoagulant Total Revenue (USD Million) (2017-2018)
Table 46. Otsuka SWOT Analysis
Table 47. Otsuka Decoagulant Product and Services
Table 48. Otsuka Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 50. AstraZeneca Decoagulant Major Business
Table 51. AstraZeneca Decoagulant Total Revenue (USD Million) (2017-2018)
Table 52. AstraZeneca SWOT Analysis
Table 53. AstraZeneca Decoagulant Product and Services
Table 54. AstraZeneca Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Genentech (Roche) Basic Information, Manufacturing Base and Competitors
Table 56. Genentech (Roche) Decoagulant Major Business
Table 57. Genentech (Roche) Decoagulant Total Revenue (USD Million) (2017-2018)
Table 58. Genentech (Roche) SWOT Analysis
Table 59. Genentech (Roche) Decoagulant Product and Services
Table 60. Genentech (Roche) Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Lilly Basic Information, Manufacturing Base and Competitors
Table 62. Lilly Decoagulant Major Business
Table 63. Lilly Decoagulant Total Revenue (USD Million) (2017-2018)
Table 64. Lilly SWOT Analysis
Table 65. Lilly Decoagulant Product and Services
Table 66. Lilly Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Decoagulant Major Business
Table 69. Pfizer Decoagulant Total Revenue (USD Million) (2017-2018)
Table 70. Pfizer SWOT Analysis
Table 71. Pfizer Decoagulant Product and Services
Table 72. Pfizer Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 74. Daiichi Sankyo Decoagulant Major Business
Table 75. Daiichi Sankyo Decoagulant Total Revenue (USD Million) (2017-2018)
Table 76. Daiichi Sankyo SWOT Analysis
Table 77. Daiichi Sankyo Decoagulant Product and Services
Table 78. Daiichi Sankyo Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. The Medicines Company Basic Information, Manufacturing Base and Competitors
Table 80. The Medicines Company Decoagulant Major Business
Table 81. The Medicines Company Decoagulant Total Revenue (USD Million) (2017-2018)
Table 82. The Medicines Company SWOT Analysis
Table 83. The Medicines Company Decoagulant Product and Services
Table 84. The Medicines Company Decoagulant Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Global Decoagulant Sales by Manufacturer (2018-2019) (K Doses)
Table 86. Global Decoagulant Revenue by Manufacturer (2018-2019) (USD Million)
Table 87. Global Decoagulant Sales by Regions (2015-2020) (K Doses)
Table 88. Global Decoagulant Sales Market Share by Regions (2015-2020)
Table 89. Global Decoagulant Revenue by Regions (2015-2020) (USD Million)
Table 90. North America Decoagulant Sales by Countries (2015-2020) (K Doses)
Table 91. North America Decoagulant Sales Market Share by Countries (2015-2020)
Table 92. North America Decoagulant Revenue by Countries (2015-2020) (USD Million)
Table 93. North America Decoagulant Revenue Market Share by Countries (2015-2020)
Table 94. Europe Decoagulant Sales by Countries (2015-2020) (K Doses)
Table 95. Europe Decoagulant Sales Market Share by Countries (2015-2020)
Table 96. Europe Decoagulant Revenue by Countries (2015-2020) (USD Million)
Table 97. Asia-Pacific Decoagulant Sales by Regions (2015-2020) (K Doses)
Table 98. Asia-Pacific Decoagulant Sales Market Share by Regions (2015-2020)
Table 99. Asia-Pacific Decoagulant Revenue by Regions (2015-2020) (USD Million)
Table 100. South America Decoagulant Sales by Countries (2015-2020) (K Doses)
Table 101. South America Decoagulant Sales Market Share by Countries (2015-2020)
Table 102. South America Decoagulant Revenue by Countries (2015-2020) (USD Million)
Table 103. South America Decoagulant Revenue Market Share by Countries (2015-2020)
Table 104. Middle East & Africa Decoagulant Sales by Countries (2015-2020) (K Doses)
Table 105. Middle East & Africa Decoagulant Sales Market Share by Countries (2015-2020)
Table 106. Middle East & Africa Decoagulant Revenue by Countries (2015-2020) (USD Million)
Table 107. Middle East & Africa Decoagulant Revenue Market Share by Countries (2015-2020)
Table 108. Global Decoagulant Sales by Type (2015-2020) (K Doses)
Table 109. Global Decoagulant Sales Share by Type (2015-2020)
Table 110. Global Decoagulant Revenue by Type (2015-2020) (USD Million)
Table 111. Global Decoagulant Revenue Share by Type (2015-2020)
Table 112. Global Decoagulant Sales by Application (2015-2020) (K Doses)
Table 113. Global Decoagulant Sales Share by Application (2015-2020)
Table 114. Global Decoagulant Sales Forecast by Regions (2021-2025) (K Doses)
Table 115. Global Decoagulant Market Share Forecast by Regions (2021-2025)
Table 116. Global Decoagulant Sales Forecast by Type (2021-2025) (K Doses)
Table 117. Global Decoagulant Market Share Forecast by Type (2021-2025)
Table 118. Global Decoagulant Sales Forecast by Application (2021-2025)
Table 119. Global Decoagulant Market Share Forecast by Application (2021-2025)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Decoagulant Picture
Figure 2. Global Sales Market Share of Decoagulant by Type in 2019
Figure 3. Platelet aggregation inhibitors (PAI) Picture
Figure 4. Low-molecular-weight Heparin (LMWH) Picture
Figure 5. Direct thrombin inhibitor (DTI) Picture
Figure 6. Direct factor Xa inhibitors (DFXa) Picture
Figure 7. Vitamin K antagonists (VKA) Picture
Figure 8. Others Picture
Figure 9. Decoagulant Sales Market Share by Application in 2018
Figure 10. VTE Picture
Figure 11. ACS/MI Picture
Figure 12. AF Picture
Figure 13. Others Picture
Figure 14. Global Decoagulant Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Decoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Decoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Decoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Decoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Decoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Decoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Decoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Decoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Decoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Decoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Decoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Decoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Decoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Decoagulant Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Decoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Decoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Decoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Decoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Decoagulant Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Decoagulant Sales Market Share by Manufacturer in 2019
Figure 35. Global Decoagulant Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Decoagulant Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Decoagulant Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 40. Global Decoagulant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Decoagulant Revenue Market Share by Regions (2015-2020)
Figure 42. Global Decoagulant Revenue Market Share by Regions in 2018
Figure 43. North America Decoagulant Sales and Growth Rate (2015-2020)
Figure 44. Europe Decoagulant Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Decoagulant Sales and Growth Rate (2015-2020)
Figure 46. South America Decoagulant Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Decoagulant Sales and Growth Rate (2015-2020)
Figure 48. North America Decoagulant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Decoagulant Sales Market Share by Countries (2015-2020)
Figure 50. North America Decoagulant Sales Market Share by Countries in 2018
Figure 51. North America Decoagulant Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Decoagulant Revenue Market Share by Countries in 2018
Figure 53. United States Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 54. Canada Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 55. Mexico Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 56. Europe Decoagulant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Decoagulant Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Decoagulant Revenue Market Share by Countries in 2019
Figure 59. Germany Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 60. UK Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 61. France Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 62. Russia Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 63. Italy Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 64. Asia-Pacific Decoagulant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Decoagulant Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Decoagulant Revenue Market Share by Regions 2019
Figure 67. China Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 68. Japan Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 69. Korea Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 70. India Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 71. Southeast Asia Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 72. South America Decoagulant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Decoagulant Sales Market Share by Countries in 2019
Figure 74. South America Decoagulant Revenue Market Share by Countries in 2019
Figure 75. Brazil Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 76. Argentina Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 77. Middle East and Africa Decoagulant Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Decoagulant Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Decoagulant Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Decoagulant Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 82. Egypt Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 83. Turkey Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 84. South Africa Decoagulant Sales and Growth Rate (2015-2020) (K Doses)
Figure 85. Global Decoagulant Sales and Growth Rate (2021-2025) (K Doses)
Figure 86. Global Decoagulant Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Decoagulant Market Forecast (2021-2025) (K Doses)
Figure 88. Europe Sales Decoagulant Market Forecast (2021-2025) (K Doses)
Figure 89. Asia-Pacific Sales Decoagulant Market Forecast (2021-2025) (K Doses)
Figure 90. South America Sales Decoagulant Market Forecast (2021-2025) (K Doses)
Figure 91. Middle East & Africa Sales Decoagulant Market Forecast (2021-2025) (K Doses)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
凝固防止剤の世界市場（～2026年） Market Analysis and Insights: Global Decoagulant Market The global Decoagulant market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Decoagulant Scope and Market Size Decoagulant market is segmented by Type, and by Applicati…- 超低分子量ヘパリン（ULMWH）の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ultra-low Molecular Weight Heparin (ULMWH) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ul…
- 超低分子量ヘパリン（ULMWH）の世界市場（～2026年） Market Analysis and Insights: Global Ultra-low Molecular Weight Heparin (ULMWH) Market The global Ultra-low Molecular Weight Heparin (ULMWH) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ultra-low Molecular Weight He…
- 腫瘍壊死因子α阻害剤の世界市場（～2026年） The tumor necrosis factor alpha (TNF-a) inhibitors represent one of the major treatment methods for inflammatory diseases. Globally, this drug class is known to be the most successful drugs in the overall pharmaceutical industry. Several conditions such as inflammations, rheumatoid arthritis (RA), i…
- 腫瘍壊死因子阻害剤の世界市場（～2026年） Market Analysis and Insights: Global Tumor Necrosis Factor Inhibitors Market The global Tumor Necrosis Factor Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tumor Necrosis Factor Inhibitors Scope and Market…